Tag(s):
FTC still waiting for a pay-for-delay ruling
Premium Article - Tuesday, 08 March 2011
The US Supreme Court has let an appeals court ruling stand allowing pharmaceutical companies to strike so-called ‘pay-for-delay’ deals with generic drug makers without violating antitrust law.
US states file brief with Supreme Court in Cipro case
Premium Article - Wednesday, 12 January 2011
A group of 32 state attorneys general have told the US Supreme Court that they need clarification on the legality of pay-for-delay pharmaceutical settlements - which only the high court can provide.
Second Circuit refuses to hear pay-for-delay lawsuit
Premium Article - Wednesday, 08 September 2010
The US Court of Appeal for the Second Circuit in New York has refused to reconsider whether a patent settlement between drugmaker Bayer and rival Barr Pharmaceuticals violates antitrust laws.
FTC claims Boehringer failed to answer subpoena
Premium Article - Wednesday, 28 October 2009
The US Federal Trade Commission says that German drugmaker Boehringer Ingelheim has refused to respond to subpoenas sent as part of an investigation of whether the company violated section 5 of the FTC Act when it paid a rival to end patent litigation.
Search GCR
Register for Free GCR Daily News
GCR April/May 2012
In this issue:
Survey: Australia • Howrey: in their words • Rod Sims interview • GCR cartel roundtable • GCR Live Law Leaders Asia-Pacific
GCR Live Events
Jun
20
GCR Live Financial Services and Competition Law 2012
Organiser: Global Competition Review
Wed, 20th June
London, United Kingdom
Jun
28
GCR Live Consumer Goods and Retail - Latin America 2012
Organiser: Global Competition Review
Thu, 28th June
São Paulo, Brasil
Oct
09
Nov
13
GCR Live 4th Annual Competition Law Review
Organiser: Global Competition Review
Tue, 13th November - Wed, 14th November
Brussels, Belgium
Feb
08
